Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Turkey / NCT07148778
Recruiting Not applicable

Effectiveness of Chatbot-Supported Web Program in Postpartum Care

NCT07148778 · tracked via the Priya Life Science Turkey tracker
Sponsor
Emine Ilkin Aydin
Phase
Not applicable
Started
2026-07-01
Last updated
2026-10-16

Condition(s) studied

Postpartum CareWeb-based TrainingChatbot-Based Training

Investigational drug(s) / intervention(s)

Educational intervention

Educational intervention: In this study, a web-based postpartum care package program supported by a chatbot will be administered to the intervention group. A pre-test will be administered to participants in the intervention group within 24-48 hours after birth. Participants in this group will be informed that they must watch the videos in the educational modules until the sixth week postpartum. Reminder messages will also be sent to participants via the website, email, and phone calls (between days 7 and 14 postpartum and week 3 postpartum). Participants who have completed the module training will be eligible for post-tests at 6 weeks postpartum and 3 months postpartum.

Study summary

The purpose of this clinical study was to evaluate the effectiveness of a web-based "Postpartum Care Package" program developed for postpartum women and delivered via a chatbot, and to examine its effects on the postpartum health of mothers and newborns.

The key questions it aims to answer are:

* What is the impact of the chatbot-supported web-based "Postpartum Care Package" program on the postpartum health of mothers and newborns?
* Does the chatbot-supported web-based "Postpartum Care Package" program increase women's accessibility and availability of postpartum care resources?

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
35 Years
Healthy volunteers
No
Inclusion Criteria: Women who will be included in the study. * Have given birth between the 37th and 41st weeks of pregnancy, * Be primigravida, * Have not been diagnosed with a high-risk pregnancy, * Have an educational level of primary school or above, * Have no communication difficulties or mental disabilities, * Have access to equipment (mobile phone, computer, tablet, internet) for web-based education, * Have experienced no complications in the mother or baby during pregnancy, childbirth, or the postpartum period, * Voluntarily agree to participate in the study, Exclusion Criteria: * Women who moved outside the province where the study was conducted during the implementation period, * Women who voluntarily withdrew from the study, * Women who did not participate in any phase of the study will not be included in the study.

Primary outcome measure(s)

  • Postpartum Physical Symptom Severity Scale — Pre-test/24-48 hours postpartum Post-test/6 weeks and 3 months postpartum
    Maternal physical health will be assessed using the Postpartum Physical Symptom Severity Scale. This four-point Likert-type scale ranges from 0 to 54, with higher scores indicating greater severity of postpartum physical symptoms.
  • Visual Analog Scale — Pre-test/24-48 hours postpartum Post-test/6 weeks and 3 months postpartum
    Mothers' physical discomfort/pain levels will be assessed using a Visual Analog Scale. The scale consists of a 10 cm horizontal line, where "0" represents no discomfort and "10" represents the most severe discomfort imaginable. Participants will be asked to mark the point on the line that best reflects their level of physical discomfort/pain during the assessment. Higher scores indicate more severe discomfort/pain.
  • Edinburgh Postpartum Depression Scale — Pre-test/24-48 hours postpartum Post-test/6 weeks and 3 months postpartum
    The Edinburgh Postnatal Depression Scale will be used to screen for depressive symptoms in postpartum women. The scale consists of 10 items on a four-point Likert-type scale. Each item is scored from 0 to 3, and the total score ranges from 0 to 30. Higher scores indicate more depressive symptoms.
  • Sexual Life Quality Scale — Pre-test/24-48 hours postpartum Post-test/6 weeks and 3 months postpartum
    The Sexual Quality of Life Scale will be used to evaluate the impact of sexual functions on the quality of life of individuals. It assesses physical, emotional, and relational aspects of sexual well-being. This Likert-type scale consists of 18 items. Higher scores reflect better sexual quality of life, while lower scores indicate deterioration in sexual well-being.
  • Breastfeeding Self-Efficacy Scale — Pre-test/24-48 hours postpartum Post-test/6 weeks and 3 months postpartum
    The Breastfeeding Self-Efficacy Scale will be used to assess mothers' levels of breastfeeding self-efficacy. It evaluates maternal perceptions regarding their skills, knowledge, and coping abilities related to breastfeeding. The scale consists of 14 items rated on a five-point Likert scale. Scores range from 14 to 70, with higher scores indicating greater breastfeeding self-efficacy.

Trial sites (1)

FacilityCityRegionStatus
Yozgat City Hospital Yozgat City Center Recruiting

Other trials for the same condition

Effect of a Respectful Maternity Care-Based Action Plan in Postpartum Care on Maternal and Neonatal Outcomes Starting soon
THE EFFECT OF REIKI ON BREASTFEEDING, PAIN AND COMFORT AFTER CESAREAN SECTION Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07148778 on ClinicalTrials.gov ↗ ← All trials in Turkey